ACADIA Pharmaceuticals Statistics
Total Valuation
ACAD has a market cap or net worth of $3.68 billion. The enterprise value is $3.05 billion.
| Market Cap | 3.68B |
| Enterprise Value | 3.05B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ACAD has 167.36 million shares outstanding. The number of shares has increased by 1.32% in one year.
| Current Share Class | 167.36M |
| Shares Outstanding | 167.36M |
| Shares Change (YoY) | +1.32% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 0.56% |
| Owned by Institutions (%) | 73.44% |
| Float | 114.81M |
Valuation Ratios
The trailing PE ratio is 16.05 and the forward PE ratio is 46.35. ACAD's PEG ratio is 3.52.
| PE Ratio | 16.05 |
| Forward PE | 46.35 |
| PS Ratio | 3.56 |
| Forward PS | 4.44 |
| PB Ratio | 4.66 |
| P/TBV Ratio | 5.67 |
| P/FCF Ratio | 24.75 |
| P/OCF Ratio | 24.66 |
| PEG Ratio | 3.52 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.98, with an EV/FCF ratio of 20.53.
| EV / Earnings | 13.32 |
| EV / Sales | 3.06 |
| EV / EBITDA | 29.98 |
| EV / EBIT | 34.50 |
| EV / FCF | 20.53 |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.88 |
| Quick Ratio | 2.63 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | 0.38 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 37.24% and return on invested capital (ROIC) is 8.21%.
| Return on Equity (ROE) | 37.24% |
| Return on Assets (ROA) | 5.56% |
| Return on Invested Capital (ROIC) | 8.21% |
| Return on Capital Employed (ROCE) | 10.65% |
| Revenue Per Employee | $1.52M |
| Profits Per Employee | $349,974 |
| Employee Count | 654 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 9.45 |
Taxes
In the past 12 months, ACAD has paid $35.97 million in taxes.
| Income Tax | 35.97M |
| Effective Tax Rate | 13.58% |
Stock Price Statistics
The stock price has increased by +43.28% in the last 52 weeks. The beta is 0.65, so ACAD's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +43.28% |
| 50-Day Moving Average | 17.38 |
| 200-Day Moving Average | 17.03 |
| Relative Strength Index (RSI) | 66.71 |
| Average Volume (20 Days) | 2,714,136 |
Short Selling Information
The latest short interest is 15.24 million, so 9.11% of the outstanding shares have been sold short.
| Short Interest | 15.24M |
| Short Previous Month | 15.26M |
| Short % of Shares Out | 9.11% |
| Short % of Float | 13.28% |
| Short Ratio (days to cover) | 8.49 |
Income Statement
In the last 12 months, ACAD had revenue of $996.28 million and earned $228.88 million in profits. Earnings per share was $1.37.
| Revenue | 996.28M |
| Gross Profit | 595.17M |
| Operating Income | 88.36M |
| Pretax Income | 45.74M |
| Net Income | 228.88M |
| EBITDA | 101.67M |
| EBIT | 88.36M |
| Earnings Per Share (EPS) | $1.37 |
Balance Sheet
The company has $681.58 million in cash and $56.01 million in debt, giving a net cash position of $625.57 million or $3.74 per share.
| Cash & Cash Equivalents | 681.58M |
| Total Debt | 56.01M |
| Net Cash | 625.57M |
| Net Cash Per Share | $3.74 |
| Equity (Book Value) | 765.24M |
| Book Value Per Share | 4.58 |
| Working Capital | 568.41M |
Cash Flow
In the last 12 months, operating cash flow was $148.96 million and capital expenditures -$523,000, giving a free cash flow of $148.44 million.
| Operating Cash Flow | 148.96M |
| Capital Expenditures | -523,000 |
| Free Cash Flow | 148.44M |
| FCF Per Share | $0.89 |
Margins
Gross margin is 59.74%, with operating and profit margins of 8.87% and 22.97%.
| Gross Margin | 59.74% |
| Operating Margin | 8.87% |
| Pretax Margin | 26.58% |
| Profit Margin | 22.97% |
| EBITDA Margin | 10.20% |
| EBIT Margin | 8.87% |
| FCF Margin | 14.90% |
Dividends & Yields
ACAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.32% |
| Shareholder Yield | -1.32% |
| Earnings Yield | 6.23% |
| FCF Yield | 4.04% |
Analyst Forecast
The average price target for ACAD is $27.00, which is 22.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $27.00 |
| Price Target Difference | 22.84% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 11.26% |
| EPS Growth Forecast (5Y) | 16.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACAD has an Altman Z-Score of 3.58 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.58 |
| Piotroski F-Score | 5 |